Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

DiGeorge Anomaly: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

DiGeorge Anomaly: 1 US clinical trial tracked, none currently recruiting.

DiGeorge Anomaly is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Sumitomo Pharma Switzerland, running 1 of these trials.

Enrollment posture brief

Registry condition digeorge-anomaly

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%DiGeorge Anomaly (this)0%
Open-enrollment share among volume-matched conditions near DiGeorge Anomaly

DiGeorge Anomaly has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for DiGeorge Anomaly on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. DiGeorge Anomaly is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on DiGeorge Anomaly records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cultured Thymus Tissue Implantation with Parathyroid Transplantation Other
1 trials
Cultured Thymus Tissue Implantation (CTTI) Biological
1 trials

US sites by state

Facility locations filed on DiGeorge Anomaly trials. A trial with sites in several states counts in each.

North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this DiGeorge Anomaly page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No DiGeorge Anomaly trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Sumitomo Pharma Switzerland sponsors the most DiGeorge Anomaly trials on record, review their full trial history before evaluating a specific study. See Sumitomo Pharma Switzerland's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This DiGeorge Anomaly condition card totals 1 registered trials; most-linked intervention Cultured Thymus Tissue Implantation with Parathyroid Transplantation; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.